Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71335-2158

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-2158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Divalproex Fig1)

Figure 1 (Divalproex Fig1)
The text appears to be a figure caption showing the results of two studies, represented by a chart or graph labeled "Figure 1". The studies are referred to as "Study 1" and "Study 2" and are measured in "YRS" and "WIRS", respectively. There is an indication of statistical significance, with "*p<0.05" suggesting a significant difference between groups. The letters "PBO", "DVPK", "P80", and "DVPX" are also included, with "PBO" representing a placebo and "DVPX" representing divalproex sodium delayed-release tablets, while the meanings of "DVPK" and "P80" are not clear from the text.*
FDA Label Image

Figure 2 (Divalproex Fig2)

Figure 2 (Divalproex Fig2)
FDA Label Image

Figure 3 (Divalproex Fig3)

Figure 3 (Divalproex Fig3)
The text describes a figure labeled as "Figure 3" showing the reduction in CPS rate. The figure includes a graph with "High Dose" and "Low Dose" labels, as well as "Improvement," "No Change," and "Worsening" categories. The x-axis displays "% of Patients."*
FDA Label Image

Figure 4 (Divalproex Fig4)

Figure 4 (Divalproex Fig4)
The text describes the mean 4-week migraine rates for a placebo group and a group taking Divalproex Sodium Delayed-Release Tablets in two different studies. The mean dose of Divalproex Sodium Delayed-Release Tablets was either 1,087 mg/day or 500 or 1,000 mg/day depending on the study.*
FDA Label Image

Chemical Structure (Divalproex Str)

Chemical Structure (Divalproex Str)
FDA Label Image

Label (Lbl713352158)

Label (Lbl713352158)
This text is a prescription drug label for Divalproex (500mg tablet) with the name of a pharmaceutical company and storage instructions. It includes product details, such as color, imprint, batch number, and Expiry Date. The label indicates that this medication is a generic equivalent of Depakote.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.